Form D · Biotechnology
INFINITY PHARMACEUTICALS, INC.
Cambridge, MA · CIK 0001113148
Offering snapshot reported Sep 24, 2012 · SEC filing
- Reported sold
- $78.5M Offering amount: $78.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 7, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 24, 2012 | Initial | $78,540,191 | No comparison | 1 | SEC filing |
| Dec 8, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-184502
Source: Form D, filed Sep 24, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Julian Adams | Executive |
| Martin Babler | Director |
| Anthony B. Evnin | Director |
| Gwen A. Fyfe | Director |
| Steve H Holtzman | Director |
| Eric S. Lander | Director |
| Patrick P Lee | Director |
| Thomas J. Lynch | Director |
| Vito J. Palombella | Executive |
| Adelene Q. Perkins | Director, Executive |
| Pedro Santabarbara | Executive |
| Norman C. Selby | Director |
| Ian F. Smith | Director |
| Michael C. Venuti | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
780 Memorial Drive
Cambridge, MA, 02139
Cambridge, MA, 02139